Related Experiment Video
Updated: Jun 18, 2026
10:16
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Is stem cell-based therapy going on or out for cardiac disease?
1Division of Cardiology, Department of Internal Medicine, Kwandong University College of Medicine, Goyang, Korea.
Korean Circulation Journal
|December 2, 2009
Summary
Stem cell therapies show promise for heart repair by improving cardiac function and promoting blood vessel growth. While direct cardiomyocyte regeneration in humans remains elusive, resident and induced pluripotent stem cells offer potential for future cardiac treatments.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Acute myocardial infarction and heart failure are major global causes of mortality.
- Current stem cell therapies have shown benefits in improving cardiac function and perfusion.
- Direct regeneration of cardiomyocytes in human hearts via stem cells has not yet been achieved.
Purpose of the Study:
- To review the current state of stem cell-based therapies for cardiac repair.
- To highlight the potential of different stem cell types in treating heart disease.
- To discuss the challenges and future directions in cardiac regeneration.
Main Methods:
- Review of recent clinical trials and scientific literature on stem cell therapy for cardiac conditions.
- Analysis of studies investigating bone marrow-derived stem cells, adult stem cells, resident cardiac stem cells, and induced pluripotent stem cells.
- Evaluation of mechanisms including angiogenesis, cardiac perfusion restoration, and cell differentiation.
Main Results:
- Stem cell therapies have demonstrated improvements in cardiac function and angiogenesis in clinical settings.
- Bone marrow-derived stem cells and other adult stem cells have successfully promoted angiogenesis and restored cardiac perfusion.
- Resident cardiac stem cells possess the capacity to differentiate into various cardiac cell types, including cardiomyocytes.
Conclusions:
- Stem cell therapy offers a promising avenue for treating heart failure post-myocardial infarction.
- While cardiomyocyte regeneration in humans is still a challenge, ongoing research into resident and induced pluripotent stem cells holds significant potential.
- Further investigation into customized stem cell therapies could revolutionize cardiac regenerative medicine.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...